EG24420A - Treatment of ophthalmic conditions - Google Patents

Treatment of ophthalmic conditions

Info

Publication number
EG24420A
EG24420A EGNA2006000587A EG24420A EG 24420 A EG24420 A EG 24420A EG NA2006000587 A EGNA2006000587 A EG NA2006000587A EG 24420 A EG24420 A EG 24420A
Authority
EG
Egypt
Prior art keywords
treatment
ophthalmic conditions
ophthalmic
conditions
Prior art date
Application number
Other languages
English (en)
Inventor
Alberto Osio Sancho
Original Assignee
Osio Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Osio Corp filed Critical Osio Corp
Application granted granted Critical
Publication of EG24420A publication Critical patent/EG24420A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/4886—Metalloendopeptidases (3.4.24), e.g. collagenase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/47—Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/10—Ophthalmic agents for accommodation disorders, e.g. myopia
    • G—PHYSICS
    • G02—OPTICS
    • G02C—SPECTACLES; SUNGLASSES OR GOGGLES INSOFAR AS THEY HAVE THE SAME FEATURES AS SPECTACLES; CONTACT LENSES
    • G02C7/00—Optical parts
    • G02C7/02—Lenses; Lens systems ; Methods of designing lenses
    • G02C7/04—Contact lenses for the eyes
    • G—PHYSICS
    • G02—OPTICS
    • G02C—SPECTACLES; SUNGLASSES OR GOGGLES INSOFAR AS THEY HAVE THE SAME FEATURES AS SPECTACLES; CONTACT LENSES
    • G02C7/00—Optical parts
    • G02C7/02—Lenses; Lens systems ; Methods of designing lenses
    • G02C7/04—Contact lenses for the eyes
    • G02C7/047—Contact lens fitting; Contact lenses for orthokeratology; Contact lenses for specially shaped corneae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F9/00—Methods or devices for treatment of the eyes; Devices for putting-in contact lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
    • A61F9/007—Methods or devices for eye surgery
    • A61F9/008—Methods or devices for eye surgery using laser

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Ophthalmology & Optometry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Optics & Photonics (AREA)
  • General Physics & Mathematics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Eyeglasses (AREA)
  • Prostheses (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Surgery (AREA)
  • Materials For Medical Uses (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
EGNA2006000587 2003-12-19 2006-06-19 Treatment of ophthalmic conditions EG24420A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
MXPA03011987A MXPA03011987A (es) 2003-12-19 2003-12-19 Metodo para el tratamiento de la presbicia induciendo cambios en el poder y fisiologia corneal.
PCT/US2004/042660 WO2005062818A2 (en) 2003-12-19 2004-12-17 Treatment of ophthalmic conditions

Publications (1)

Publication Number Publication Date
EG24420A true EG24420A (en) 2009-05-25

Family

ID=34740239

Family Applications (1)

Application Number Title Priority Date Filing Date
EGNA2006000587 EG24420A (en) 2003-12-19 2006-06-19 Treatment of ophthalmic conditions

Country Status (17)

Country Link
US (6) US8475831B2 (es)
EP (1) EP1706094B1 (es)
JP (4) JP2007514760A (es)
KR (1) KR20070012329A (es)
CN (1) CN100591354C (es)
AU (1) AU2004308326B2 (es)
BR (1) BRPI0417785A (es)
CA (1) CA2549333C (es)
CR (1) CR8453A (es)
EC (1) ECSP066657A (es)
EG (1) EG24420A (es)
HK (1) HK1099232A1 (es)
IL (1) IL176397A (es)
MX (1) MXPA03011987A (es)
RU (1) RU2006126077A (es)
WO (1) WO2005062818A2 (es)
ZA (1) ZA200605950B (es)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA03011987A (es) 2003-12-19 2005-06-23 Osio Sancho Alberto Metodo para el tratamiento de la presbicia induciendo cambios en el poder y fisiologia corneal.
JP4653437B2 (ja) * 2004-08-04 2011-03-16 株式会社ニデック オルソケラトロジー処方支援システム
WO2007044967A2 (en) * 2005-10-13 2007-04-19 Lai Shui T Intrastromal refractive surgery by inducing shape change of the cornea
US7726811B2 (en) 2006-02-14 2010-06-01 Lai Shui T Subjective wavefront refraction using continuously adjustable wave plates of Zernike function
US7748844B2 (en) 2006-06-15 2010-07-06 Lai Shui T High visual acuity contact lenses
WO2008014330A2 (en) 2006-07-25 2008-01-31 Lai Shui T Method of making high precision optics having a wavefront profile
GB0724558D0 (en) * 2007-12-15 2008-01-30 Sharma Anant Optical correction
ATE517366T1 (de) * 2007-12-20 2011-08-15 Mor Research Applic Ltd Hyperosmotische augenkontaktlinse
MY156101A (en) * 2009-05-04 2016-01-15 Coopervision Int Holding Co Lp Ophthalmic lenses and reduction of accommodative error
US20100298335A1 (en) * 2009-05-22 2010-11-25 Kaufman Herbert E Preparations and Methods for Ameliorating or Reducing Presbyopia
US8299079B2 (en) 2009-05-22 2012-10-30 Kaufman Herbert E Preparations and methods for ameliorating or reducing presbyopia
JP2013501963A (ja) 2009-10-22 2013-01-17 クーパーヴィジョン インターナショナル ホウルディング カンパニー リミテッド パートナーシップ 近視または遠視の進行を阻止または遅鈍するコンタクトレンズセットおよびその方法
CN104093404B (zh) 2011-09-20 2016-12-07 阿勒根公司 用于治疗老花眼、轻度远视和不规则散光的组合物和方法
IN2015KN00596A (es) * 2012-08-10 2015-07-17 Osio Corp D B A Yolia Health
KR101454646B1 (ko) * 2012-11-05 2014-10-27 (주)한국비엠아이 히알루로니다아제의 안정화 제제 및 이를 포함하는 액상제제
US11079613B2 (en) * 2013-03-05 2021-08-03 EyeYon Medical Ltd. Contact lens drug depot
JP6674462B2 (ja) * 2014-12-02 2020-04-01 アヴェドロ・インコーポレーテッドＡｖｅｄｒｏ，Ｉｎｃ． 眼の架橋処置のためのシステム、方法及び組成物
JP2018513117A (ja) 2015-03-05 2018-05-24 オークランド ユニサービシズ リミテッドＡｕｃｋｌａｎｄ Ｕｎｉｓｅｒｖｉｃｅｓ Ｌｉｍｉｔｅｄ 眼科用組成物およびその使用方法
US9709822B2 (en) 2015-03-11 2017-07-18 Vance M. Thompson Orthokeratology lens with displaced shaping zone
EP3108874A1 (en) * 2015-06-26 2016-12-28 TRB Chemedica AG Ophthalmologic pharmaceutical composition
BR112019002967A2 (pt) 2016-08-19 2019-05-14 Orasis Pharmaceuticals Ltd. composição farmacêutica oftálmica, métodos de corrigir presbiopia, de reduzir o tamanho de uma pupila, de induzir miose, de aumentar a profundidade de campo, de diminuir a grandeza de aberrações de ordem superior e de melhorar a acuidade visual não corrigida de perto e de longe, implante, e, kit.
EP3593817A4 (en) * 2017-03-06 2021-04-07 Tsubota Laboratory, Inc. MODEL FOR THE INDUCTION OF MURINE MYOPIA AND ENDOPLASMATIC RETICULUM STRESS INHIBITOR FOR THE PREVENTION OR SUPPRESSION OF MYOPIA
EP3605223B1 (en) 2017-03-23 2022-04-27 Sony Group Corporation Projector equipped with detection function
CN110785149B (zh) * 2017-04-28 2022-10-04 华柏恩视觉研究中心有限公司 用于控制近视进展的系统、方法和装置
CA3078631A1 (en) * 2017-10-11 2019-04-18 Jacob M. Waugh Methods and compositions for topical delivery
CN112105320A (zh) * 2018-01-05 2020-12-18 犹他大学研究基金会 治疗近视进展
EP3861402A1 (en) * 2018-12-21 2021-08-11 Alcon Inc. Multi-curvature edge for ophthalmic lenses
US20210000910A1 (en) 2019-07-03 2021-01-07 Jysk Skin Solutions Pte Ltd Topical compositions
US20220334409A1 (en) * 2019-09-25 2022-10-20 Nthalmic Holding Pty Ltd A contact lens solution for myopia management
KR20230147164A (ko) * 2021-02-22 2023-10-20 텐드 헬스 아이엔씨 대변 샘플 수집 및 처리 시스템
US12083204B2 (en) 2022-06-02 2024-09-10 L'oreal Topical composition for homeostatic delivery of nitric oxide and uses thereof

Family Cites Families (103)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5413510B2 (es) * 1973-08-28 1979-05-31
US3957049A (en) * 1973-10-09 1976-05-18 Neefe Charles W Rechargeable drug delivery method
US4525043A (en) 1977-11-11 1985-06-25 Leonard Bronstein Contact lens
JPS6033474B2 (ja) * 1978-05-11 1985-08-02 藤沢薬品工業株式会社 新規なヒアルロニダ−ゼｂｍｐ−８２３１およびその製造法
US4418991A (en) * 1979-09-24 1983-12-06 Breger Joseph L Presbyopic contact lens
US4484922A (en) * 1981-06-25 1984-11-27 Rosenwald Peter L Occular device
US4571039A (en) * 1983-04-15 1986-02-18 Stanley Poler Eye-medicating contact-lens construction
US4540417A (en) * 1983-05-02 1985-09-10 Stanley Poler Eye-medicating haptic
US4601556A (en) 1983-10-26 1986-07-22 Siviglia Nick C Corneal contact lens for the eye of a patient with keratoconus disease and method of making the same
US5316926A (en) * 1983-11-25 1994-05-31 Miles Inc. Method for the microbiological production of non-antigenic hyaluronic acid
GB8504025D0 (en) 1985-02-16 1985-03-20 Biopharm Ltd Hyaluronidase
US4592752A (en) * 1985-08-02 1986-06-03 Neefe Charles W Non-optical corneal drug delivery
US4851513A (en) * 1985-09-06 1989-07-25 Minnesota Mining And Manufacturing Company Viscoelastic collagen solution for opthalmic use and method of preparation
US4713446A (en) * 1985-09-06 1987-12-15 Minnesota Mining And Manufacturing Company Viscoelastic collagen solution for ophthalmic use and method of preparation
US5484432A (en) 1985-09-27 1996-01-16 Laser Biotech, Inc. Collagen treatment apparatus
US4820016A (en) * 1986-02-21 1989-04-11 American Telephone And Telegraph Company, At&T Bell Laboratories Waveguide-containing communications and sensing systems
SE456245B (sv) * 1986-07-09 1988-09-19 Pharmacia Ab Enzympreparation innehallande krillhyaluronidas
US4759746A (en) * 1987-05-14 1988-07-26 Straus Jeffrey G Retro-bulbar needle
US4969912A (en) * 1988-02-18 1990-11-13 Kelman Charles D Human collagen processing and autoimplant use
US4881543A (en) * 1988-06-28 1989-11-21 Massachusetts Institute Of Technology Combined microwave heating and surface cooling of the cornea
US5360611A (en) * 1988-10-03 1994-11-01 Alcon Laboratories, Inc. Pharmaceutical compositions and methods of treatment of the cornea following ultraviolet laser irradiation
NO164844C (no) * 1988-10-24 1990-11-21 Norsk Hydro As Fremgangsmaate ved utvinning av enzymer fra krepsdyr.
EP0456724B1 (en) * 1989-01-27 1995-05-03 Immunolytics, Inc. Composition and method for treating benign prostatic hypertrophy
US4897349A (en) * 1989-04-28 1990-01-30 Medchem Products, Inc. Biosynthesis of hyaluronic acid
US4952045B1 (en) 1989-05-26 2000-08-08 Contex Inc Corneal contact lens and method for treating myopea
US5015577A (en) * 1989-08-29 1991-05-14 Board Of Regents, The University Of Texas System DNA encoding hyaluronate synthase
US5201764A (en) * 1990-02-28 1993-04-13 Autogenesis Technologies, Inc. Biologically compatible collagenous reaction product and articles useful as medical implants produced therefrom
ZA912770B (en) 1990-04-16 1992-01-29 Bethesda Eye Inst Enzymatic disinsertion of vitreous body
US5196027A (en) * 1990-05-02 1993-03-23 Thompson Keith P Apparatus and process for application and adjustable reprofiling of synthetic lenticules for vision correction
EP0459148B1 (en) 1990-05-29 1996-01-03 Ocular Research Of Boston Inc. Dry eye treatment composition
US5779696A (en) * 1990-07-23 1998-07-14 Sunrise Technologies International, Inc. Method and apparatus for performing corneal reshaping to correct ocular refractive errors
US5163956A (en) * 1990-11-06 1992-11-17 General Electric Company Methods and lenticules for modifying the cornea
US5144630A (en) * 1991-07-29 1992-09-01 Jtt International, Inc. Multiwavelength solid state laser using frequency conversion techniques
EP1159941A3 (en) 1991-10-15 2003-09-17 Ista Pharmaceuticals, Inc. Formulations for use in enzyme-orthokeratology
US5270051A (en) 1991-10-15 1993-12-14 Harris Donald H Enzyme-orthokeratology
US5788957A (en) * 1991-10-15 1998-08-04 Advanced Corneal Systems, Inc. Enzyme-orthokeratology
US5465737A (en) * 1992-07-15 1995-11-14 Schachar; Ronald A. Treatment of presbyopia and other eye disorders
US5354331A (en) 1992-07-15 1994-10-11 Schachar Ronald A Treatment of presbyopia and other eye disorders
US5492135A (en) * 1992-09-09 1996-02-20 Devore; Dale P. Collagen modulators for use in photoablation excimer laser keratectomy
US5520679A (en) 1992-12-03 1996-05-28 Lasersight, Inc. Ophthalmic surgery method using non-contact scanning laser
US5593877A (en) * 1993-03-11 1997-01-14 The Rockefeller University Nucleic acid and recombinant production of vespid venom hyaluronidase
US5496726A (en) * 1993-04-16 1996-03-05 Lucky Limited Streptococcus zooepidemicus medium and process for preparing hyaluronic acid
US5894002A (en) 1993-12-13 1999-04-13 Ciba Vision Corporation Process and apparatus for the manufacture of a contact lens
JPH0867617A (ja) 1994-08-31 1996-03-12 Tsuneo Nanba 化粧料
US5756552A (en) * 1994-10-13 1998-05-26 Wakamoto Pharmaceutical Co., Ltd. Lyophilized pharmaceutical preparations capable of providing aqueous drug composition having property of reversible thermosetting gelation
US5792103A (en) * 1995-02-03 1998-08-11 Schwartz; Daniel M. Viscosurgical method and apparatus
US5518732A (en) * 1995-02-14 1996-05-21 Chiron Vision, Inc. Bio-erodible ophthalmic shield
US5695509A (en) * 1995-03-10 1997-12-09 El Hage; Sami G. Aspherical optical molds for continuous reshaping the cornea based on topographical analysis
US5747027A (en) * 1995-04-07 1998-05-05 The Regents Of The University Of California BH55 hyaluronidase
US6610292B2 (en) * 1995-11-22 2003-08-26 Ista Pharmaceuticals, Inc. Use of hyaluronidase in the manufacture of an ophthalmic preparation for liquefying vitreous humor in the treatment of eye disorders
US5866120A (en) * 1995-11-22 1999-02-02 Advanced Corneal Systems, Inc. Method for accelerating clearance of hemorrhagic blood from the vitreous humor with hyaluronidase
US6099121A (en) 1996-06-07 2000-08-08 Bausch & Lomb Incorporated Contact lens design
US6010219A (en) * 1996-06-28 2000-01-04 Contex, Inc. Fenestrated contact lens for treating myopia
US5815237A (en) 1996-07-01 1998-09-29 Bausch & Lomb Incorporated Contact lens and method for making the same
BR9712824A (pt) * 1996-09-13 1999-12-21 Advanced Medicine Research Ins Composição oftálmica de fator neurotrófico, agente de tratamento de desordem funcional do nervo ótico e método para tratamento de desordem funcional do nervo ótico
US6123938A (en) * 1996-10-17 2000-09-26 The Regents Of The University Of California Human urinary hyaluronidase
WO1998030900A2 (en) * 1997-01-06 1998-07-16 Klaus Trier Aps Screening method for compounds active in treating myopia and hypermetropia
US6037144A (en) * 1997-01-29 2000-03-14 Staar Surgical Ag Method of preparing a biological material for use in ophthalmology
US5815327A (en) 1997-03-14 1998-09-29 Xerox Corporation Photolithographic method of fabricating fresnel lenses
WO1998052090A1 (en) 1997-05-16 1998-11-19 Corrective Vision, Inc. Improved contact lens
US5963297A (en) 1997-06-27 1999-10-05 Reim; Thomas Russell Orthokeratology contact lens and method therefor
US6161544A (en) * 1998-01-28 2000-12-19 Keratoform, Inc. Methods for accelerated orthokeratology
AU2677299A (en) 1998-02-17 1999-08-30 Schepens Eye Research Institute, Inc., The Use of hyaluronidase to reduce viscoelastic related increases in intraocular pressure
KR20010041806A (ko) * 1998-03-09 2001-05-25 에드워드 에이취. 댄스 효소 각막교정술에 사용되는 각막 경화제의 용도
US6595986B2 (en) * 1998-10-15 2003-07-22 Stephen Almeida Multiple pulse photo-dermatological device
US6263879B1 (en) 1998-11-10 2001-07-24 J. T. Lin Treatment of presbyopia and other eye disorders using a scanning laser system
IL127209A0 (en) * 1998-11-23 1999-09-22 Bio Silk Ltd Composition and method for treatment of hypertrophic skin accumulations and their prevention
US6335006B1 (en) * 1999-03-22 2002-01-01 Boston Innovative Optics, Inc. Methods of using agents that act on the epithelial sheet of a human eye
AU4672300A (en) * 1999-04-29 2000-11-17 Ista Pharmaceuticals, Inc Biochemical methods that eliminate corneal scars, opacification and haze
US6258082B1 (en) * 1999-05-03 2001-07-10 J. T. Lin Refractive surgery and presbyopia correction using infrared and ultraviolet lasers
US6946440B1 (en) * 1999-09-15 2005-09-20 Dewoolfson Bruce H Composition for stabilizing corneal tissue during or after orthokeratology lens wear
US6428785B1 (en) * 1999-10-28 2002-08-06 Immunolytics Inc. Method and composition for treating prostate cancer
US6426208B1 (en) * 1999-11-12 2002-07-30 Harbor-Ucla Research And Education Institute Recombinant α-L-iduronidase, methods for producing and purifying the same and methods for treating diseases caused by deficiencies thereof
US6569661B1 (en) * 1999-11-12 2003-05-27 Biomarin Pharmaceutical Inc. Recombinant α-L-iduronidase, methods for producing and purifying the same and methods for treating diseases caused by deficiencies thereof
US6585971B1 (en) * 1999-11-12 2003-07-01 Harbor-Ucla Research And Education Institute Recombinant α-L-iduronidase, methods for producing and purifying the same and methods for treating disease caused by deficiencies thereof
RU2166785C1 (ru) 2000-03-17 2001-05-10 ЗАО "Диафарм" Очищающий раствор для контактных линз
US6886936B2 (en) 2000-07-28 2005-05-03 Ocular Sciences, Inc. Contact lenses with blended microchannels
US6543897B1 (en) * 2000-11-17 2003-04-08 Hsiao-Ching Tung Orthokeratology contact lens
US6652095B2 (en) 2000-11-17 2003-11-25 Hsiao-Ching Tung Orthokeratology and bi-focal contact lens
US6902548B1 (en) * 2001-03-19 2005-06-07 Ed Schuler Use of Streptomyces hyalurolyticus enzyme in ophthalmic treatments
JP2002350787A (ja) * 2001-03-21 2002-12-04 Menicon Co Ltd コンタクトレンズ
US6745776B2 (en) * 2001-04-10 2004-06-08 David B. Soll Methods for reducing postoperative intraocular pressure
US6939364B1 (en) * 2001-10-09 2005-09-06 Tissue Adhesive Technologies, Inc. Composite tissue adhesive
US6773699B1 (en) * 2001-10-09 2004-08-10 Tissue Adhesive Technologies, Inc. Light energized tissue adhesive conformal patch
US6875427B1 (en) * 2001-10-09 2005-04-05 Tissue Adhesive Technologies, Inc. Light energized tissue adhesive
US6780840B1 (en) * 2001-10-09 2004-08-24 Tissue Adhesive Technologies, Inc. Method for making a light energized tissue adhesive
US20030139737A1 (en) * 2002-01-24 2003-07-24 J.T. Lin Method and apparatus for treatment of presbyopia by lens relaxation and anterior shift
US6997553B2 (en) 2002-08-07 2006-02-14 Global-Ok Vision, Inc. Contact lens for reshaping the altered corneas of post refractive surgery, previous ortho-K of keratoconus
MXPA05002669A (es) * 2002-09-13 2005-08-19 Ocular Sciences Inc Dispositivos y metodos para mejorar la vision.
GB0229577D0 (en) 2002-12-19 2003-01-22 Bausch & Lomb Contact lens manufacture
WO2005022242A1 (en) 2003-08-27 2005-03-10 The Institute For Eye Research Soft lens orthokeratology
RU2231814C1 (ru) 2003-10-29 2004-06-27 Егорова Галина Борисовна Универсальный пробный набор жестких газопроницаемых контактных линз для коррекции кератоконуса
MXPA03011987A (es) 2003-12-19 2005-06-23 Osio Sancho Alberto Metodo para el tratamiento de la presbicia induciendo cambios en el poder y fisiologia corneal.
US20050256065A1 (en) * 2004-01-26 2005-11-17 Permasight Method for stabilizing changes in corneal curvature in an eye by administering compositions containing stabilizing ophthalmic agents
MXPA05000125A (es) 2004-12-17 2006-06-19 Sancho Alberto Osio Metodo para el tratamiento de condiciones oftalmicas.
US7559649B2 (en) 2005-01-12 2009-07-14 Dakota Sciences, LLC Corneal-scleral orthokeratology contact lens
JP2007195818A (ja) 2006-01-27 2007-08-09 Akihiro Oguri オルソケラトロジー用コンタクトレンズ
US20080024717A1 (en) 2006-07-28 2008-01-31 Stanton Kim Contact lens used in orthokeratology
JP2008112120A (ja) 2006-10-30 2008-05-15 Eyemed Co Ltd 多面フィッティングオルソｋレンズ
JP4992051B2 (ja) 2008-06-09 2012-08-08 株式会社アイメディ商事 角膜矯正療法用処方コンタクトレンズの選定装置
CA2791748A1 (en) 2010-03-03 2011-09-09 Brien Holden Vision Institute Corneal remodelling contact lenses and methods of treating refractive error using corneal remodelling
US8366272B1 (en) 2011-08-19 2013-02-05 Contact Lens Precision Laboratories Limited Fitting contact lenses for irregular corneas
IN2015KN00596A (es) 2012-08-10 2015-07-17 Osio Corp D B A Yolia Health

Also Published As

Publication number Publication date
ECSP066657A (es) 2006-11-24
US20070122450A1 (en) 2007-05-31
IL176397A (en) 2012-03-29
KR20070012329A (ko) 2007-01-25
US20150216952A1 (en) 2015-08-06
JP2011153153A (ja) 2011-08-11
JP2017057219A (ja) 2017-03-23
JP5715875B2 (ja) 2015-05-13
US20160367647A1 (en) 2016-12-22
US20170266267A1 (en) 2017-09-21
US8679521B2 (en) 2014-03-25
JP2015180354A (ja) 2015-10-15
JP6397876B2 (ja) 2018-09-26
US8475831B2 (en) 2013-07-02
AU2004308326B2 (en) 2011-02-10
CA2549333C (en) 2014-08-05
WO2005062818A2 (en) 2005-07-14
JP2007514760A (ja) 2007-06-07
CN1901882A (zh) 2007-01-24
CA2549333A1 (en) 2005-07-14
IL176397A0 (en) 2006-10-05
HK1099232A1 (en) 2007-08-10
US9931382B2 (en) 2018-04-03
JP6084661B2 (ja) 2017-02-22
CN100591354C (zh) 2010-02-24
US9241980B2 (en) 2016-01-26
CR8453A (es) 2006-12-07
WO2005062818A8 (en) 2006-10-05
WO2005062818B1 (en) 2005-11-24
US9566317B2 (en) 2017-02-14
MXPA03011987A (es) 2005-06-23
WO2005062818A3 (en) 2005-10-13
EP1706094A4 (en) 2012-03-28
US20140271597A1 (en) 2014-09-18
EP1706094B1 (en) 2018-07-18
RU2006126077A (ru) 2008-01-27
BRPI0417785A (pt) 2007-03-20
EP1706094A2 (en) 2006-10-04
ZA200605950B (en) 2007-12-27
US8877228B2 (en) 2014-11-04
US20140017220A1 (en) 2014-01-16
AU2004308326A1 (en) 2005-07-14

Similar Documents

Publication Publication Date Title
EG24420A (en) Treatment of ophthalmic conditions
EP1755584A4 (en) TREATMENT OF MYOPIA
IL173351A0 (en) Therapy of ocular disorders
GB2415378B (en) Treatment of neurodegenerative conditions
EP1617844A4 (en) TREATMENT OF NEUROLOGICAL DISEASES
GB2422373B (en) Treatment of neurodegenerative conditions
GB0404656D0 (en) Treatment of spinal conditions
GB0320238D0 (en) Treatment of disease
PL371281A1 (en) Methods and compositions for the treatment of eye diseases
EP1651237A4 (en) METHOD FOR THE TREATMENT OF DERMATOLOGICAL ILLNESSES
EP1675547A4 (en) GLUCOCEREBROSIDE TREATMENT OF ILLNESSES
GB0302572D0 (en) Method of treatment
GB0306309D0 (en) Method of treatment
IL174595A0 (en) Glucocerebroside treatment of disease
GB0300783D0 (en) Treatment of neurodegenerative conditions
EP1691776A4 (en) TREATMENT OF AIDS
GB0217493D0 (en) Novel methods of treatment
PT1706094T (pt) Tratamento de condições oftalmológicas
GB0221712D0 (en) Methods of treatment
GB0327975D0 (en) Methods of treatment
HU0302933D0 (en) Treatment of diseases
GB0312289D0 (en) Treatment of the eye
GB0322921D0 (en) Methods of treatment
AU2004905035A0 (en) Treatment of Ophthalmic Conditions
GB0313801D0 (en) Novel methods of treatment